Oaky67, appreciate your valuable insights.
Yeah I have heard that too, ie. if you get onto it later, if there is already a fair bit of damage and inflammation is higher...then yep, you may need a few courses over time.
I would try and get boosters. They should be much more open to your request as you have already had iPPS.
There are a few papers involving animal models that have remarkable changes in morphology of tissues and bone if iPPS is administered earlier. Cartilage traditionally has been much harder to grow/repair but even here we are seeing increases for the first time as documented by PAR in their 008 study.
Though I'm motivated by the SP one day going up (!!) I also long for the day PAR set up a longitudinal study powered for DM at a scale. That read out will be also incredible.
Do let us know if you manage to get boosters and your future journey with iPPS.
Best of luck
Mozz
- Forums
- ASX - By Stock
- The OA solution...
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.20%
!
46.5¢

Oaky67, appreciate your valuable insights.Yeah I have heard that...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
46.5¢ |
Change
0.010(2.20%) |
Mkt cap ! $184.8M |
Open | High | Low | Value | Volume |
45.5¢ | 48.0¢ | 44.0¢ | $534.2K | 1.168M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5245 | 45.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23000 | 0.450 |
1 | 10000 | 0.440 |
1 | 23255 | 0.430 |
2 | 45000 | 0.425 |
2 | 21531 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 10000 | 1 |
0.475 | 13560 | 2 |
0.480 | 90598 | 3 |
0.485 | 10000 | 1 |
0.490 | 18000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online